202 related articles for article (PubMed ID: 7611175)
21. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
[TBL] [Abstract][Full Text] [Related]
22. Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma.
Toikkanen S; Pylkkänen L; Joensuu H
Br J Cancer; 1997; 76(9):1234-40. PubMed ID: 9365176
[TBL] [Abstract][Full Text] [Related]
23. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
Chen TL; Luo I; Mikhail N; Rasková J; Raska K
Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949
[TBL] [Abstract][Full Text] [Related]
24. The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre.
Camplejohn RS; Ash CM; Gillett CE; Raikundalia B; Barnes DM; Gregory WM; Richards MA; Millis RR
Br J Cancer; 1995 Jan; 71(1):140-5. PubMed ID: 7819030
[TBL] [Abstract][Full Text] [Related]
25. Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma.
Thurman SA; Schnitt SJ; Connolly JL; Gelman R; Silver B; Harris JR; Recht A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):152-9. PubMed ID: 15093911
[TBL] [Abstract][Full Text] [Related]
26. DNA index, S-phase fraction, histological grade and prognosis in breast cancer.
O'Reilly SM; Camplejohn RS; Barnes DM; Millis RR; Allen D; Rubens RD; Richards MA
Br J Cancer; 1990 May; 61(5):671-4. PubMed ID: 2159768
[TBL] [Abstract][Full Text] [Related]
27. Cell cycle flow cytometric analysis in the diagnosis and management of colorectal carcinoma.
Sampedro A; Salas-Bustamante A; López-Artimez M; García-Muñíz JL; Urdiales G
Anal Quant Cytol Histol; 1999 Aug; 21(4):347-52. PubMed ID: 10560513
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
Haffty BG; Toth M; Flynn S; Fischer D; Carter D
J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
[TBL] [Abstract][Full Text] [Related]
29. Ductal breast carcinomas with whole chromosome gains as a particular subset of near-diploid tumors with different metastasis free survival.
Elie C; Molist R; Asselain B; Dutrillaux B; Muleris M
Breast Cancer Res Treat; 2005 Aug; 92(3):279-85. PubMed ID: 16155799
[TBL] [Abstract][Full Text] [Related]
30. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
31. Mitotic counts provide additional prognostic information in grade II mammary carcinoma.
Lynch J; Pattekar R; Barnes DM; Hanby AM; Camplejohn RS; Ryder K; Gillett CE
J Pathol; 2002 Mar; 196(3):275-9. PubMed ID: 11857489
[TBL] [Abstract][Full Text] [Related]
32. Ovarian tumors of low malignant potential. Correlation of DNA index and S-phase fraction with histopathologic grade and clinical outcome.
Demirel D; Laucirica R; Fishman A; Owens RG; Grey MM; Kaplan AL; Ramzy I
Cancer; 1996 Apr; 77(8):1494-500. PubMed ID: 8608534
[TBL] [Abstract][Full Text] [Related]
33. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
[TBL] [Abstract][Full Text] [Related]
34. Quantitative DNA analysis and proliferation in breast carcinomas. A comparison between image analysis and flow cytometry.
Lee AK; Wiley B; Dugan JM; Hamilton WH; Loda M; Heatley GJ; Cook L; Silverman ML
Pathol Res Pract; 1992 Jun; 188(4-5):428-32. PubMed ID: 1329051
[TBL] [Abstract][Full Text] [Related]
35. The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancer.
Yildirim-Assaf S; Coumbos A; Hopfenmüller W; Foss HD; Stein H; Kühn W
J Clin Pathol; 2007 Jun; 60(6):649-55. PubMed ID: 17557867
[TBL] [Abstract][Full Text] [Related]
36. The S-phase fraction of the aneuploid cell subpopulation is the biologically relevant one in aneuploid breast cancers.
Martinez-Arribas F; Nuñez-Villar MJ; Lucas AR; Sanchez J; Tejerina A; Schneider J
Breast Cancer Res Treat; 2005 Jul; 92(1):77-80. PubMed ID: 15980994
[TBL] [Abstract][Full Text] [Related]
37. Comparative predictive value of three prognostic markers--S-phase fraction, PCNA and Mitotic count on axillary lymph node metastasis in carcinoma breast.
Pervez S; Khan MN; Nasir MI
J Ayub Med Coll Abbottabad; 2007; 19(1):3-5. PubMed ID: 17867469
[TBL] [Abstract][Full Text] [Related]
38. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
Masood S; Bui MM; Lu L
Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198
[TBL] [Abstract][Full Text] [Related]
39. [The objective comparison of nuclear DNA content with nuclear grade in breast cancer].
Yamamoto N
Nihon Geka Gakkai Zasshi; 1995 Apr; 96(4):236-44. PubMed ID: 7753019
[TBL] [Abstract][Full Text] [Related]
40. Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance.
Gaffey MJ; Frierson HF; Mills SE; Boyd JC; Zarbo RJ; Simpson JF; Gross LK; Weiss LM
Mod Pathol; 1993 Nov; 6(6):721-8. PubMed ID: 8302815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]